Hemolytic uremic syndrome after autologous BMT without TBI.
Raybon
K B
KB
Snyder
M J
MJ
Halvorson
R D
RD
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002330:Carmustine / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D003561:Cytarabine / Q000009:adverse effects; D005047:Etoposide / Q000009:adverse effects; D006463:Hemolytic-Uremic Syndrome / Q000145:classification / Q000209:etiology*; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D008297:Male; D019172:Transplantation Conditioning / Q000009:adverse effects; D014182:Transplantation, Autologous; D014916:Whole-Body Irradiation
D003561:Cytarabine; D005047:Etoposide; D003520:Cyclophosphamide; D002330:Carmustine